![Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study]()
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II studyEisen, Tim; Shparyk, Yaroslav; Macleod, Nicholas; Jones, Robert; Wallenstein, Gudrun; Temple, Graham; Khder, Yasser; Dallinger, Claudia; Studeny, Matus; Loembe, Arsene-Bienvenu; Bondarenko, Igor · Investigational New Drugs · 2013